ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 165 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $222,000 | +54.2% | 10,813 | +49.5% | 0.00% | – |
Q2 2023 | $144,000 | -92.0% | 7,234 | -93.1% | 0.00% | – |
Q1 2023 | $1,795,000 | +784.2% | 104,765 | +909.0% | 0.00% | – |
Q4 2022 | $203,000 | +2155.6% | 10,383 | +1848.0% | 0.00% | – |
Q3 2022 | $9,000 | -96.5% | 533 | -97.2% | 0.00% | – |
Q2 2022 | $259,000 | +547.5% | 18,829 | +643.3% | 0.00% | – |
Q1 2022 | $40,000 | -79.5% | 2,533 | -71.7% | 0.00% | – |
Q4 2021 | $195,000 | +91.2% | 8,941 | +162.3% | 0.00% | – |
Q3 2021 | $102,000 | -15.0% | 3,409 | +25.3% | 0.00% | – |
Q2 2021 | $120,000 | -92.5% | 2,720 | -92.4% | 0.00% | – |
Q1 2021 | $1,592,000 | +19800.0% | 35,886 | +26286.8% | 0.00% | – |
Q4 2020 | $8,000 | +300.0% | 136 | -9.3% | 0.00% | – |
Q1 2020 | $2,000 | -92.3% | 150 | -86.7% | 0.00% | – |
Q4 2019 | $26,000 | +62.5% | 1,124 | +77.0% | 0.00% | – |
Q3 2018 | $16,000 | -52.9% | 635 | -63.5% | 0.00% | – |
Q2 2018 | $34,000 | -24.4% | 1,741 | -27.3% | 0.00% | – |
Q1 2018 | $45,000 | – | 2,394 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |